Be inclusive when caring for transgender people with diabetes

It is critical for diabetes care and education specialists to create an inclusive space and be mindful of an individual’s concerns when caring for transgender people with diabetes, according to a presenter.
Gender-affirming hormone therapy can lead to effects on glycemic outcomes and may alter cardiovascular risk for transgender people with diabetes, said Jodie Gee, PharmD, BCACP, clinical associate professor at University of Houston College of Pharmacy and ambulatory care clinical pharmacist at Vecino Family Health Center. During a talk at the Association of Diabetes Care & Education

Wegovy benefits consistent regardless of frailty level

In a new analysis of the SELECT trial published in JAMA Cardiology, semaglutide 2.4 mg improved clinical outcomes compared with placebo regardless of frailty level.
For the analysis, the 17,604 patients (mean age, 61.6 years; 72.3% men) from SELECT, a trial that demonstrated semaglutide 2.4 mg (Wegovy, Novo Nordisk) reduced risk for major cardiovascular outcomes by 20% compared with placebo, were stratified into three categories according to a 31-item frailty index: not frail (31%), more frail (47%) and most frail (22%).
“Practice is currently highly variable, which is due, in part, to

Elevated pulse pressure in older women not linked to menopause

Increased pulse pressure among older women, previously hypothesized to be menopause-related, may be an independent risk for cardiovascular disease among older women, researchers reported.
Pulse pressure is defined as the difference between systolic and diastolic BP and may serve as a predictor of aortic stiffness and risk for heart disease among older women, whose pulse pressure is on average higher than men, according to data published in Hypertension.
“Many people believe that the change in pulse pressure is linked to the hormonal shifts caused by menopause. Here, we are evaluating

Q&A: How to make a pivot in your healthcare career

The first step in making a big career change is recognizing your “early symptoms,” according to an expert.
At the 2026 Women in Nephrology Annual Leadership Conference, Nuria Maria Pastor-Soler, MD, PhD, associate professor of medicine at University of Vermont, will speak to women in medicine considering a career change and how to navigate the complex emotions and practical concerns that come with making a career shift.
“I want to talk about what it takes to start thinking about a career pivot and how to identify those ‘early symptoms’ of wanting to pivot,” Pastor-Soler told Healio.
Healio spoke